Clinical & Operational Challenges of COVID-19 Vaccine Development & Future Opportunities

Time: 9:00 am
day: Day Two


  • Vaccine efficacy against disease versus infection / transmission: Defining clinical trial endpoints for a new pathogen with limited pre-existing evidence
  • Establishing vaccine efficacy when placebo-controlled trials become more and more difficult as vaccines are being licensed and deployed
  • Need for correlates of protection, newly emerging variants and vaccine adaptation, and vaccine safety and pharmacovigilance